Literature DB >> 18932278

Facilitating effects of berberine on rat pancreatic islets through modulating hepatic nuclear factor 4 alpha expression and glucokinase activity.

Zhi-Quan Wang1, Fu-Er Lu, San-Hua Leng, Xin-Sheng Fang, Guang Chen, Zeng-Si Wang, Li-Ping Dong, Zhong-Qing Yan.   

Abstract

AIM: To observe the effect of berberine on insulin secretion in rat pancreatic islets and to explore its possible molecular mechanism.
METHODS: Primary rat islets were isolated from male Sprague-Dawley rats by collagenase digestion and treated with different concentrations (1, 3, 10 and 30 micromol/L) of berberine or 1 micromol/L Glibenclamide (GB) for 24 h. Glucose-stimulated insulin secretion (GSIS) assay was conducted and insulin was determined by radioimmunoassay. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was performed to evaluate cytotoxicity. The mRNA level of hepatic nuclear factor 4 alpha (HNF4alpha) was determined by reverse transcription polymerase chain reaction (RT-PCR). Indirect immunofluorescence staining and Western blot analysis were employed to detect protein expression of HNF4alpha in the islets. Glucokinase (GK) activity was measured by spectrophotometric method.
RESULTS: Berberine enhanced GSIS rather than basal insulin secretion dose-dependently in rat islets and showed no significant cytotoxicity on islet cells at the concentration of 10 mumol/L. Both mRNA and protein expressions of HNF4alpha were up-regulated by berberine in a dose-dependent manner, and GK activity was also increased accordingly. However, GB demonstrated no regulatory effects on HNF4alpha expression or GK activity.
CONCLUSION: Berberine can enhance GSIS in rat islets, and probably exerts the insulinotropic effect via a pathway involving HNF4alpha and GK, which is distinct from sulphonylureas (SUs).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18932278      PMCID: PMC2760199          DOI: 10.3748/wjg.14.6004

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

Review 1.  Desensitization of insulin secretion by depolarizing insulin secretagogues.

Authors:  Ingo Rustenbeck; Antje Wienbergen; Claudia Bleck; Anne Jörns
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

2.  Hepatocyte nuclear factor-4alpha is essential for glucose-stimulated insulin secretion by pancreatic beta-cells.

Authors:  Atsuko Miura; Kazuya Yamagata; Masafumi Kakei; Hiroyasu Hatakeyama; Noriko Takahashi; Kenji Fukui; Takao Nammo; Kazue Yoneda; Yusuke Inoue; Frances M Sladek; Mark A Magnuson; Haruo Kasai; Junichiro Miyagawa; Frank J Gonzalez; Iichiro Shimomura
Journal:  J Biol Chem       Date:  2005-12-23       Impact factor: 5.157

3.  Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy.

Authors:  Marcela Brissova; Michael J Fowler; Wendell E Nicholson; Anita Chu; Boaz Hirshberg; David M Harlan; Alvin C Powers
Journal:  J Histochem Cytochem       Date:  2005-05-27       Impact factor: 2.479

Review 4.  Glucokinase as pancreatic beta cell glucose sensor and diabetes gene.

Authors:  F Matschinsky; Y Liang; P Kesavan; L Wang; P Froguel; G Velho; D Cohen; M A Permutt; Y Tanizawa; T L Jetton
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

5.  The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion.

Authors:  Rana K Gupta; Marko Z Vatamaniuk; Catherine S Lee; Reed C Flaschen; James T Fulmer; Franz M Matschinsky; Stephen A Duncan; Klaus H Kaestner
Journal:  J Clin Invest       Date:  2005-03-03       Impact factor: 14.808

6.  Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.

Authors:  Weijia Kong; Jing Wei; Parveen Abidi; Meihong Lin; Satoru Inaba; Cong Li; Yanling Wang; Zizheng Wang; Shuyi Si; Huaining Pan; Shukui Wang; Jingdan Wu; Yue Wang; Zhuorong Li; Jingwen Liu; Jian-Dong Jiang
Journal:  Nat Med       Date:  2004-11-07       Impact factor: 53.440

7.  Stevioside does not cause increased basal insulin secretion or beta-cell desensitization as does the sulphonylurea, glibenclamide: studies in vitro.

Authors:  Jianguo Chen; Per Bendix Jeppesen; Reziwanggu Abudula; Stig E U Dyrskog; Michele Colombo; Kjeld Hermansen
Journal:  Life Sci       Date:  2005-11-02       Impact factor: 5.037

8.  Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1)

Authors:  K Yamagata; H Furuta; N Oda; P J Kaisaki; S Menzel; N J Cox; S S Fajans; S Signorini; M Stoffel; G I Bell
Journal:  Nature       Date:  1996-12-05       Impact factor: 49.962

9.  Unresponsiveness to glibenclamide during chronic treatment induced by reduction of ATP-sensitive K+ channel activity.

Authors:  J Kawaki; K Nagashima; J Tanaka; T Miki; M Miyazaki; T Gonoi; N Mitsuhashi; N Nakajima; T Iwanaga; H Yano; S Seino
Journal:  Diabetes       Date:  1999-10       Impact factor: 9.461

10.  Insulin sensitizing and insulinotropic action of berberine from Cortidis rhizoma.

Authors:  Byoung-Seob Ko; Soo Bong Choi; Seong Kyu Park; Jin Sun Jang; Yeong Eun Kim; Sunmin Park
Journal:  Biol Pharm Bull       Date:  2005-08       Impact factor: 2.233

View more
  10 in total

1.  Berberine Induces Cell Apoptosis through Cytochrome C/Apoptotic Protease-Activating Factor 1/Caspase-3 and Apoptosis Inducing Factor Pathway in Mouse Insulinoma Cells.

Authors:  Xin Fang; Xiao-Liang Miao; Jun-Li Liu; Dong-Wei Zhang; Min Wang; Dan-Dan Zhao; Qian-Qian Mu; Na Yu; Fang-Fang Mo; Hong-Ping Yin; Si-Hua Gao
Journal:  Chin J Integr Med       Date:  2015-07-04       Impact factor: 1.978

2.  Berberine acutely activates the glucose transport activity of GLUT1.

Authors:  Alexandra Cok; Christina Plaisier; Matthew J Salie; Daniel S Oram; Jude Chenge; Larry L Louters
Journal:  Biochimie       Date:  2011-04-29       Impact factor: 4.079

3.  Berberine protects against high fat diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis.

Authors:  Ana P Gomes; Filipe V Duarte; Patricia Nunes; Basil P Hubbard; João S Teodoro; Ana T Varela; John G Jones; David A Sinclair; Carlos M Palmeira; Anabela P Rolo
Journal:  Biochim Biophys Acta       Date:  2011-10-17

4.  Glucose plus metformin compared with glucose alone on β-cell function in mouse pancreatic islets.

Authors:  Mahmoud Hashemitabar; Somayeh Bahramzadeh; Sadegh Saremy; Freshteh Nejaddehbashi
Journal:  Biomed Rep       Date:  2015-06-11

Review 5.  An overview on antidiabetic medicinal plants having insulin mimetic property.

Authors:  D K Patel; S K Prasad; R Kumar; S Hemalatha
Journal:  Asian Pac J Trop Biomed       Date:  2012-04

Review 6.  Application of berberine on treating type 2 diabetes mellitus.

Authors:  Bing Pang; Lin-Hua Zhao; Qiang Zhou; Tian-Yu Zhao; Han Wang; Cheng-Juan Gu; Xiao-Lin Tong
Journal:  Int J Endocrinol       Date:  2015-03-11       Impact factor: 3.257

7.  Berberine Attenuated Proliferation, Invasion and Migration by Targeting the AMPK/HNF4α/WNT5A Pathway in Gastric Carcinoma.

Authors:  Qian Hu; Lingli Li; Xin Zou; Lijun Xu; Ping Yi
Journal:  Front Pharmacol       Date:  2018-10-19       Impact factor: 5.810

Review 8.  Barberry in the treatment of obesity and metabolic syndrome: possible mechanisms of action.

Authors:  Safieh Firouzi; Mahsa Malekahmadi; Majid Ghayour-Mobarhan; Gordon Ferns; Hamid Reza Rahimi
Journal:  Diabetes Metab Syndr Obes       Date:  2018-11-08       Impact factor: 3.168

9.  Amorphous solid dispersion of Berberine mitigates apoptosis via iPLA2β/Cardiolipin/Opa1 pathway in db/db mice and in Palmitate-treated MIN6 β-cells.

Authors:  Junnan Li; Hongwei Du; Meishuang Zhang; Zhi Zhang; Fei Teng; Yali Zhao; Wenyou Zhang; Yang Yu; Linjing Feng; Xinming Cui; Ming Zhang; Tzongshi Lu; Fengying Guan; Li Chen
Journal:  Int J Biol Sci       Date:  2019-06-02       Impact factor: 6.580

10.  Gastric cancer biomarkers; A systems biology approach.

Authors:  Mohammad Saberi Anvar; Zarrin Minuchehr; Mohsen Shahlaei; Samira Kheitan
Journal:  Biochem Biophys Rep       Date:  2018-02-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.